Wednesday, Apr 16 2025 | Time 20:01 Hrs(IST)
Business EconomyPosted at: Apr 11 2025 1:35AM


Granules India announces completion of 100 pc acquisition of Swiss-based Senn Chemicals

Hyderabad, Apr 10 (UNI) Granules India Limited on Thursday announced the successful acquisition of Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing.
This transaction also marks Granules’ foray into the CDMO space, with Senn’s established CDMO business providing a strong platform for growth. The acquisition enhances Granules’ global footprint and provides access to a regulated market client base and highly skilled scientific talent in Europe.
This marks a strategic milestone in Granules’ transformation into a science- and innovation-led organization and extends its capabilities into the fast-growing peptide therapeutics segment, the Hyderabad based pharma company said in a release here.
The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides Private Limited, acquired 100 percent of the equity of Senn Chemicals from the founding Senn family.
Senn Chemicals has built a strong reputation as a specialist in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), serving innovators and brand owners across pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets.
The Senn Chemicals brand and its operations in Dielsdorf, Switzerland, will operate under Granules’ ownership, with a commitment to maintaining the company’s scientific excellence and customer focus.
Dr Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India, said, "The acquisition of Senn Chemicals AG marks a pivotal step in Granules’ strategic evolution into a science- and innovation-led organization. Together, we aim to drive meaningful impact in the complex therapeutics space."
The acquisition will enable Granules to accelerate development and manufacturing of GLP-1 receptor agonists and other peptide-based APIs, addressing the growing demand in anti-diabetic, anti-obesity, and other next-generation therapeutic areas.
Granules and Senn have already initiated joint development activities in this space, with a broader peptide API pipeline planned.
UNI KNR SS
Please log in to get detailed story.
Tags: #Granules India announces completion of 100 pc acquisition of Swiss-based Senn Chemicals
More News

Matix Group to foray into Industrial and Speciality Chemicals Manufacturing with more than Rs 2600 Cr investment

16 Apr 2025 | 6:53 PM

Kolkata, Apr 16 (UNI) Nishant Kanodia- promoted Matix Group is expanding its footprint in the industrial and speciality chemical manufacturing sector.

see more..

SBI Card and Tata Digital partner to launch Tata Neu SBI Card

16 Apr 2025 | 5:44 PM

Kolkata, Apr 16 (UNI) SBI Card in partnership with Tata Digital announced the launch of Tata Neu SBI Card on Wednesday.

see more..

Kottayam-Kochi Rubber Market Rates

16 Apr 2025 | 5:02 PM

Kottayam, Apr 16 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..
Rupee gains 8 paise against USD

Rupee gains 8 paise against USD

16 Apr 2025 | 5:01 PM

Mumbai, Apr 16 (UNI) The Rupee remained firm on Wednesday too, rising 8 paise to close at 85.68 against USD, on selling of US Dollar from foreign banks and exporters, dealers at the Forex Market said.

see more..

GRSE commences construction of state-of-the-art Acoustic Research Ship for NPOL, DRDO

16 Apr 2025 | 5:00 PM

Kolkata, Apr 16 (UNI) It was a red-letter day for Garden Reach Shipbuilders and Engineers (GRSE) Ltd on Wednesday when it commenced construction of an Acoustic Research Ship (ARS) being built for the Naval Physical and Oceanographic Laboratory (NPOL), a unit of the Defence Research and Development Organisation (DRDO).

see more..